Seeks to further amend notification No. 16/2017-Customs, dated the 20th April, 2017 so to exempt certain drugs for supply under Patient Assistance Programme run by specified pharmaceutical companies. - 09/2025 - Customs -Tariff
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Customs exemption for patient assistance programmes expands to include specified drugs supplied under designated company programmes. The notification amends Notification No. 16/2017-Customs by inserting serial entries listing specific drugs, the named Patient Assistance Programmes, and the associated pharmaceutical companies; supplies of those drugs under the listed programmes are exempted from customs duty. The amendment is made under section 25(1) of the Customs Act and takes effect on the stated commencement date.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption for patient assistance programmes expands to include specified drugs supplied under designated company programmes.
The notification amends Notification No. 16/2017-Customs by inserting serial entries listing specific drugs, the named Patient Assistance Programmes, and the associated pharmaceutical companies; supplies of those drugs under the listed programmes are exempted from customs duty. The amendment is made under section 25(1) of the Customs Act and takes effect on the stated commencement date.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.